Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
However, the lack of human clinical trials means long-term safety in people remains unknown
BPC-157 / Thymosin Beta-4 Strength: 15 mg / 15 mg A high-strength premium combination created for more advanced recovery and performance support plans
Reference standard for in-vitro NNMT activity inhibition, NAD+ biosynthesis pathway modulation, and adipogenesis regulation research
The study found that NNMT inhibitors "reduced intracellular 1-MNA, increased intracellular NAD+ and S-(5-adenosyl)-L-methionine (SAM), and suppressed lipogenesis." This metabolic improvement occurs within days of starting treatment, before any weight loss becomes measurable
The compound then received GRAS (Generally Recognized as Safe) designation from the FDA for use as a food ingredient, which is a separate regulatory category from drug approval
NAD+ / SIRT1: Associated with elevated NAD+ and SIRT1 activation in preclinical studies [2] [3]
US$ 24.72
US$ 29.28
US$ 22.35
US$ 22.90
US$ 24.08
